Torkel Richert
Overview
Explore the profile of Torkel Richert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
151
Followers
0
Related Specialties
Related Specialties
Co-Authors
Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Richert T, Stallwitz A, Nordgren J
Harm Reduct J
. 2023 Oct;
20(1):146.
PMID: 37833801
Background: Social work with people who use drugs (PWUD) has traditionally focused on abstinence and rehabilitation. In recent years, harm reduction has gained an increasingly more important role in social...
2.
Richert T
Front Psychiatry
. 2022 Jun;
13:882128.
PMID: 35656345
Background: Street level drug economies are often described as hierarchical and gender-segregated arenas where men hold high positions and control the supply of drugs, and where women are confined to...
3.
Nordgren J, Richert T, Stallwitz A
Int J Drug Policy
. 2022 Apr;
104:103672.
PMID: 35405454
Background: Since the 1980s, Swedish drug policy has combined a restrictive zero tolerance approach with the vision of a "drug-free society". However, in recent years, access to harm reduction services...
4.
Svensson B, Richert T, Johnson B
Nordisk Alkohol Nark
. 2020 Sep;
37(1):69-85.
PMID: 32934594
Aims: To examine parents' experiences of abuse directed at them by their adult children with drug problems. Material And Method: The material consists of 32 qualitative interviews on child-to-parent abuse...
5.
Richert T, Anderberg M, Dahlberg M
Subst Abuse Treat Prev Policy
. 2020 Jun;
15(1):43.
PMID: 32580732
Background: Young people with substance use problems face a high risk of co-occurring mental health problems, something that may involve a more difficult life situation, social problems as well as...
6.
Johnson B, Richert T
Harm Reduct J
. 2019 May;
16(1):31.
PMID: 31046774
Background: Opioid substitution treatment (OST) with methadone or buprenorphine is the most effective means of treating opioid dependence. If these substances are used by people who are not undergoing OST,...
7.
Richert T, Johnson B
Harm Reduct J
. 2015 Apr;
12:1.
PMID: 25889208
Background: It is well known that illicit use of methadone and buprenorphine is common among people with an opioid dependence. Less notice has been taken of the fact that these...
8.
Johnson B, Richert T
J Subst Abuse Treat
. 2015 Mar;
54:50-5.
PMID: 25744650
Aims: Methadone and buprenorphine diversion by patients in opioid substitution treatment (OST) is a poorly understood phenomenon. We study the norms and attitudes on diversion among OST patients, including the...
9.
Johnson B, Richert T
J Addict Dis
. 2014 Dec;
34(1):1-17.
PMID: 25496247
Diversion-the practice of patients selling or sharing their medication-is a much debated problem of opioid substitution treatment. Regular diversion by patients was studied at 11 opioid substitution treatment programs in...
10.
Johnson B, Richert T
Int J Drug Policy
. 2014 Dec;
26(2):183-90.
PMID: 25465344
Background: Diversion--patients who sell or share their medication--is a hotly debated but relatively unresearched phenomenon. We have investigated the prevalence of self-reported diversion of methadone and buprenorphine at OST programs...